Kong Z, Cai S, Xie W, Chen J, Xie J, Yang F, et al
Novo Nordisk Patient Assistance Program (PAP): Provides Wegovy, Ozempic, and Saxenda free to patients without insurance who meet income criteria
Both meds can drive improved blood sugar control and potentially reduce markers of cardiovascular risk, but tolerability differs
Those on strong glucose-lowering medications: Risk of dangerously low blood sugar increases
Behavioural and new pharmacological treatments for constipation: getting the balance right
PlexusDx sources all compounded medications from licensed 503A pharmacies, meeting rigorous pharmaceutical standards for sterility, potency, and purity